by Zeteo Biomedical | Mar 15, 2021 | Press Release
TEXGHS Global Health Security Event Features International Agenda of Companies and Speakers AUSTIN, TX – 15 March 2021 – Zeteo Biomedical will present its nasal vaccine packaging and delivery device technologies at the TEXGHS Global Health Security Demo Day scheduled...
by Zeteo Biomedical | Mar 10, 2021 | Press Release
Sublingual delivery is an emerging strategy for vaccines AUSTIN, TX – 10 March 2021 – Zeteo Biomedical a privately held, biomedical device company, announced today it has been awarded a United States Patent for its “Oral Delivery Device and Methods” (US Patent...
by Zeteo Biomedical | Nov 17, 2020 | Partners
A nasal vaccine that can be self-administered is crucial to protect global populations against pandemic virus threats AUSTIN, TX – 17 November 2020 –(send2press)– Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the...
by Zeteo Biomedical | Jun 1, 2020 | Press Release
Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals AUSTIN, TX – 01 June 2020 — (PR.com) – Zeteo Biomedical LLC announced today the availability of the ZEOx1...
by Zeteo Biomedical | May 20, 2020 | Press Release
Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats AUSTIN, TX – 20 May 2020 –(pr.com)– Zeteo Biomedical LLC, Inc., a privately held, medical...
